HomepagePRGO • NYSE
add
Perrigo
Vorige slotkoers
$Â 25,06
Dag-range
$Â 25,03 - $Â 25,57
Jaar-range
$Â 23,14 - $Â 33,46
Beurswaarde
3,43Â mld. USD
Gem. volume
1,73Â mln.
Koers/winst
-
Dividendrendement
4,62%
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | dec 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 1,14Â mld. | -1,61% |
Bedrijfskosten | 117,10Â mln. | -64,85% |
Netto inkomsten | -44,50Â mln. | -37,77% |
Netto winstmarge | -3,91 | -40,14% |
Winst per aandeel | 0,93 | 8,14% |
EBITDA | 349,10Â mln. | 93,84% |
Effectief belastingtarief | 159,29% | — |
Balans
Totale activa
Totale passiva
(USD) | dec 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 558,80Â mln. | -24,93% |
Totale activa | 9,65Â mld. | -10,74% |
Totale passiva | 5,33Â mld. | -11,80% |
Totaal aandelenvermogen | 4,32 mld. | — |
Uitstaande aandelen | 136,46 mln. | — |
Koers-boekwaardeverhouding | 0,79 | — |
Rendement op activa | 6,45% | — |
Rendement op kapitaal | 7,59% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | dec 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -44,50Â mln. | -37,77% |
Operationele kasstroom | 312,60Â mln. | 49,78% |
Kasstroom uit beleggingen | -37,10Â mln. | -62,72% |
Kasstroom uit financiering | -1,15Â mld. | -2.487,67% |
Nettomutatie in liquide middelen | -904,70Â mln. | -691,31% |
Vrije kasstroom | 517,39Â mln. | 45,97% |
Over
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Opgericht
1887
Website
Werknemers
8.379